A medical Invention by a Bengaluru-based scientist is designated as a “breakthrough device” by the US Food and Drug Administration (FDA)’s Centre for Devices and Radiological Health in treating liver, pancreatic and breast cancer.
Rajah Vijay Kumar developed a Cytotron which aids in tissue engineering of cancer cells, altering how specific proteins are regulated to stop these cells from multiplying and spreading.
A communique from the FDA wing sent to Shreis Scalene Sciences, the company that had taken the device to the US stated “We are pleased to inform you that your device and proposed indication for use meets the criteria and have been granted designation as a breakthrough device.
The inventor also said that the device will be produced in India as it hardly uses any imported parts. Cytotron is prepared to cause degeneration of uncontrolled growth of tissues. Letter from FDA also stated that It is indicated for treating protein-linked, abnormally regenerating disorders such as neoplastic disease, and allowing extended progression-free survival, with pain relief, palliation, improved quality and dignity of life.
After nearly 30 years of research into cellular pathways and interactions with specifically modulated fast radio bursts, Kumar successfully developed Cytotron at the Centre for Advanced Research and Development, which is headquartered in Bhopal. Kumar also said it is an amazing feeling that after so many years of hard work, against all odds, an institution like the USFDA is designating our work as a breakthrough in the treatment of three types of cancers.
It’s very hard for new technologies to come in the battle of devices used to treat cancer. And he is very pleased as it’s even rarer for an Indian device to get breakthrough status in the US. The Centre for Devices and Radiological Health is responsible for pre-market approval of all medical devices in the US, ensuring they are safe for use and effective.
Kumar also shared that Cytotron is already an approved medical device and is in use in the UAE, Mexico, Malaysia and Hong Kong, among others.
Working Process: Cytotron (generically known as rotational field quantum magnetic resonance) uses fast radio bursts (FRB), high energy and powerful short radio bursts in which both electric and magnetic components of the electromagnetic signals are “circularly” polarised.